LRP6 mutation in a family with early coronary disease and metabolic risk factors

被引:482
作者
Mani, Arya [1 ]
Radhakrishnan, Jayaram
Wang, He
Mani, Alaleh
Mani, Mohammad-Ali
Nelson-Williams, Carol
Carew, Khary S.
Mane, Shrikant
Najmabadi, Hossein
Wu, Dan
Lifton, Richard P.
机构
[1] Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA
[2] Howard Hughes Med Inst, Dept Genet & Mol Biophys, New Haven, CT 06510 USA
[3] Howard Hughes Med Inst, Dept Biochem, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA
[5] Amirkabir Univ Technol, Dept Mat Sci, Tehran 15875 4413, Iran
[6] Azad Univ Tehran, Dept Human Sci, Tehran 13185 786, Iran
[7] Social Welf & Rehab Sci Univ, Ctr Gene Res, Tehran 19875 383, Iran
关键词
D O I
10.1126/science.1136370
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Coronary artery disease ( CAD) is the leading cause of death worldwide and is commonly caused by a constellation of risk factors called the metabolic syndrome. We characterized a family with autosomal dominant early CAD, features of the metabolic syndrome (hyperlipidemia, hypertension, and diabetes), and osteoporosis. These traits showed genetic linkage to a short segment of chromosome 12p, in which we identified a missense mutation in LRP6, which encodes a co-receptor in the Wnt signaling pathway. The mutation, which substitutes cysteine for arginine at a highly conserved residue of an epidermal growth factor-like domain, impairs Wnt signaling in vitro. These results link a single gene defect in Wnt signaling to CAD and multiple cardiovascular risk factors.
引用
收藏
页码:1278 / 1282
页数:5
相关论文
共 26 条
[1]   Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family [J].
Brown, SD ;
Twells, RCJ ;
Hey, PJ ;
Cox, RD ;
Levy, ER ;
Soderman, AR ;
Metzker, ML ;
Caskey, CT ;
Todd, JA ;
Hess, JF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) :879-888
[2]   Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders [J].
Caughey, B ;
Lansbury, PT .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :267-298
[3]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[4]   An SCN9A channelopathy causes congenital inability to experience pain [J].
Cox, James J. ;
Reimann, Frank ;
Nicholas, Adeline K. ;
Thornton, Gemma ;
Roberts, Emma ;
Springell, Kelly ;
Karbani, Gulshan ;
Jafri, Hussain ;
Mannan, Jovaria ;
Raashid, Yasmin ;
Al-Gazali, Lihadh ;
Hamamy, Henan ;
Valente, Enza Maria ;
Gorman, Shaun ;
Williams, Richard ;
McHale, Duncan P. ;
Wood, John N. ;
Gribble, Fiona M. ;
Woods, C. Geoffrey .
NATURE, 2006, 444 (7121) :894-898
[5]   Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion [J].
Fujino, T ;
Asaba, H ;
Kang, MJ ;
Ikeda, Y ;
Sone, H ;
Takada, S ;
Kim, DH ;
Ioka, RX ;
Ono, M ;
Tomoyori, H ;
Okubo, M ;
Murase, T ;
Kamataki, A ;
Yamamoto, J ;
Magoori, K ;
Takahashi, S ;
Miyamoto, Y ;
Oishi, H ;
Nose, M ;
Okazaki, M ;
Usui, S ;
Imaizumi, K ;
Yanagisawa, M ;
Sakai, J ;
Yamamoto, TT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) :229-234
[6]   Molecular medicine - The cholesterol quartet [J].
Goldstein, JL ;
Brown, MS .
SCIENCE, 2001, 292 (5520) :1310-1312
[7]   LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development [J].
Gong, YQ ;
Slee, RB ;
Fukai, N ;
Rawadi, G ;
Roman-Roman, S ;
Reginato, AM ;
Wang, HW ;
Cundy, T ;
Glorieux, FH ;
Lev, D ;
Zacharin, M ;
Oexle, K ;
Marcelino, J ;
Suwairi, W ;
Heeger, S ;
Sabatakos, G ;
Apte, S ;
Adkins, WN ;
Allgrove, J ;
Arslan-Kirchner, M ;
Batch, JA ;
Beighton, P ;
Black, GCM ;
Boles, RG ;
Boon, LM ;
Borrone, C ;
Brunner, HG ;
Carle, GF ;
Dallapiccola, B ;
De Paepe, A ;
Floege, B ;
Halfhide, ML ;
Hall, B ;
Hennekam, RC ;
Hirose, T ;
Jans, A ;
Jüppner, H ;
Kim, CA ;
Keppler-Noreuil, K ;
Kohlschuetter, A ;
LaCombe, D ;
Lambert, M ;
Lemyre, E ;
Letteboer, T ;
Peltonen, L ;
Ramesar, RS ;
Romanengo, M ;
Somer, H ;
Steichen-Gersdorf, E ;
Steinmann, B .
CELL, 2001, 107 (04) :513-523
[8]   Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes [J].
Grant, SFA ;
Thorleifsson, G ;
Reynisdottir, I ;
Benediktsson, R ;
Manolescu, A ;
Sainz, J ;
Helgason, A ;
Stefansson, H ;
Emilsson, V ;
Helgadottir, A ;
Styrkarsdottir, U ;
Magnusson, KP ;
Walters, GB ;
Palsdottir, E ;
Jonsdottir, T ;
Gudmundsdottir, T ;
Gylfason, A ;
Saemundsdottir, J ;
Wilensky, RL ;
Reilly, MP ;
Rader, DJ ;
Bagger, Y ;
Christiansen, C ;
Gudnason, V ;
Sigurdsson, G ;
Thorsteinsdottir, U ;
Gulcher, JR ;
Kong, A ;
Stefansson, K .
NATURE GENETICS, 2006, 38 (03) :320-323
[9]   LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling:: Arrows point the way [J].
He, X ;
Semenov, M ;
Tamai, K ;
Zeng, X .
DEVELOPMENT, 2004, 131 (08) :1663-1677
[10]   Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY [J].
Horikawa, Y ;
Iwasaki, N ;
Hara, M ;
Furuta, H ;
Hinokio, Y ;
Cockburn, BN ;
Lindner, T ;
Yamagata, K ;
Ogata, M ;
Tomonaga, O ;
Kuroki, H ;
Kasahara, T ;
Iwamoto, Y ;
Bell, GI .
NATURE GENETICS, 1997, 17 (04) :384-385